X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Oncotarget

期刊標題檢索 ONCOTARGET 最新評論: Has been kicked out, the journal can no longer be found on the SCI jo... (2023-08-04)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Oncotarget]您好,您是該頁面的第 633964 位訪客。

期刊簡介
期刊名稱Oncotarget Oncotarget

(According to the latest JCR data, this journal is not indexed in the JCR.)
LetPub Score
3.7
50 ratings
Rate

Reputation
3.1

Influence
3.2

Speed
9.3

期刊簡稱ONCOTARGET
ISSN1949-2553
h-index91
CiteScore
CiteScoreSJRSNIPCiteScore Rank
6.600.7890.592
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q2107 / 404

自引率 (2023-2024)N.A.自引率趨勢
掲載範囲
Information not localized
官方網站http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget
在線稿件提交http://oncotarget.msubmit.net/cgi-bin/main.plex
開放訪問Yes
出版商Impact Journals LLC
主題領域Oncogenes
出版國/地區United States
發行頻率月刊
創刊年2009
每年文章數6625每年文章數趨勢
黃金OA百分比0.00%
Web of Science 四分位
2023-2024
WOS Quartile: Q0

N/A
索引 (SCI or SCIE)
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1949-2553%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Sort of slow, 4-8 Week(s)
競爭力 *來自作者的數據: Difficult
參考鏈接
相關期刊 【Oncotarget】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Journal of Extracellular VesiclesH-index: 0

    CiteScore: 27.30
    AGING CELLH-index: 113

    CiteScore: 14.40
    Science SignalingH-index: 128

    CiteScore: 9.50
    Cell Death DiscoveryH-index: 0

    CiteScore: 8.30
    Stem Cell ReportsH-index: 55

    CiteScore: 10.50
    CELLULAR ONCOLOGYH-index: 31

    CiteScore: 10.30
    Frontiers in Cell and Developmental BiologyH-index: 0

    CiteScore: 9.70
    Stem Cell Reviews and ReportsH-index: 61

    CiteScore: 9.30
    Cell RegenerationH-index: 0

    CiteScore: 5.80
    Cell Adhesion & MigrationH-index: 0

    CiteScore: 6.40
    學科內最受檢索的期刊 頁面查看次數
    Frontiers in Cell and Developmental Biology202345
    Cell Death Discovery107018
    Stem Cell Reports81276
    Science Signaling65700
    Journal of Extracellular Vesicles44107
    CELLULAR ONCOLOGY35742
    Current Stem Cell Research & Therapy35004
    AGING CELL33547
    Stem Cell Reviews and Reports31737
    Analytical Cellular Pathology26466
  •  

    Oncotarget Oncotarget
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/187)
  [Oncotarget] 的評論撰寫評論
作者: 墟散孤晴


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-04 16:57:26 評論於
Has been kicked out, the journal can no longer be found on the SCI journal list
(0) 讚! | 墟散孤晴

作者: 断门星津


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-10 09:28:23 評論於
It's still the rewards of 2018, don't get too excited
(0) 讚! | 断门星津

作者: 东风红凤


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-25 09:08:43 評論於
Wasn't this already kicked out? Why is there still ****?
(0) 讚! | 东风红凤

作者: May Mathilda


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-04 16:16:41 評論於
Where is so good, I Xiaobo want to rely on it after graduation
(0) 讚! | May Mathilda

作者: May Mathilda


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-04 14:02:54 評論於
This magazine article is of poor quality! It's as bad as that Asia Pacific magazine back in the day ?
(0) 讚! | May Mathilda

作者: 太山金钟


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-02-09 10:52:13 評論於
What does resurrection mean?
(0) 讚! | 太山金钟

作者: 维尔娜菲茨杰拉德


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 18:04:00 評論於
Number of articles published each year, whether only invited submissions are accepted (some authors have chosen journals that cannot submit articles), and requirements for publication on specific topics
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 08:07:12 評論於
Please translate the following paragraph into English and Japanese and provide the translations under the headings ":" and ":"
(0) 讚! | 维尔娜菲茨杰拉德

作者: 龙鳞孝礼


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 13:12:37 評論於
Should I choose both established journals and newly published journals?
(0) 讚! | 龙鳞孝礼

作者: 北国博达


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 08:54:40 評論於
In addition to the content and quality of the article, what else should be considered when selecting articles?
(0) 讚! | 北国博达

作者: 邻家飞跃


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-14 16:13:02 評論於
I feel that the quality of the articles is much worse than PLOS ONE, which is also a water journal, especially the recent few issues are terrible. I don't think it's likely to improve
(0) 讚! | 邻家飞跃

作者: 穆里尔谢里登


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-11 08:28:57 評論於
PubMed and Scopus index completely different journals
(0) 讚! | 穆里尔谢里登

作者: 无冬书亮


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-22 12:45:43 評論於
Research focus: Tumor experiences shared: Articles from 2021 have all been indexed by PubMed, I estimate that a resurrection is not far away
(0) 讚! | 无冬书亮

作者: 重阳天风


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-07-13 18:17:11 評論於
Can he ruin the academic community? You're overestimating him, or maybe you don't have a high caliber yourself
(0) 讚! | 重阳天风

作者: 东京光明


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-04-12 19:38:55 評論於
Keep it up!
(0) 讚! | 东京光明

作者: 魔都梦晨


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-03-23 22:06:47 評論於
It's unlikely
(0) 讚! | 魔都梦晨

作者: 宫古梦森


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-02-21 21:55:17 評論於
Reported already
(0) 讚! | 宫古梦森

作者: 穆里尔谢里登


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-01-25 10:37:18 評論於
Fucking fraud, go to hell. Ruining the domestic academic community
(0) 讚! | 穆里尔谢里登

作者: 坠星倩影


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-12-12 10:11:58 評論於
Strongly agree with these garbage and dishonest companies!! Advertising everywhere!
(0) 讚! | 坠星倩影

作者: Marsh Laurie


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-12-12 08:12:48 評論於
It is you assholes who have ruined the reputation of Chinese authors by creating a large number of garbage papers and fake papers to stink up the domestic scientific research community! I wish you all the worst luck and that you step on shit every time you go out
(0) 讚! | Marsh Laurie

作者: 天霜忆青


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-12-10 19:57:04 評論於
Please translate the following paragraph into English and Japanese, and title it ":" and ":"
(0) 讚! | 天霜忆青

作者: 卢子凰


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2020-09-24 10:57:16 評論於
Let me record it: The manuscript was submitted at the end of 2015. At that time, I was lacking in experience and didn’t know it will become to a valueless journal. The level of the articles at that time was not too low. It was a pity for the research results. It took 2 months from review to acceptance. There were few comments, and it was soon accepted after the revision.

(3) 讚! | 卢子凰

作者: 尚萍酱吖


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-09-21 11:01:37 評論於
 (0) 讚! | 尚萍酱吖  

作者: 瑞丹氏


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-09-16 19:44:55 評論於
Can this journal be revived?
(0) 讚! | 瑞丹氏

作者: 龙鳞依诺


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-08-19 21:24:47 評論於
When are you coming back?
(0) 讚! | 龙鳞依诺

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/187)

開始撰寫 [Oncotarget] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*